Back to VRTX
DAVENPORT & Co LLC VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
5
Latest value
$106.2M
Q3 2026
Peak value
$106.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $85.3M |
| Q4 2025 | $95.9M |
| Q1 2026 | $93.7M |
| Q2 2026 | $103M |
| Q3 2026 | $106.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $106.2M | 202.8K | — | — |
| Q2 2026 | $103M | 207.1K | — | — |
| Q1 2026 | $93.7M | 210.2K | — | — |
| Q4 2025 | $95.9M | 211.6K | — | — |
| Q3 2025 | $85.3M | 217.3K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B